Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
1 Introduction Organopalladium compounds have recently emerged as a highly promising and versatile class of metal-based anticancer agents, offering new opportunities in the design of cytotoxic drugs with improved selectivity, stability, and tunability [1-20].
1 Introduction After the pioneering discoveries of Breslow,[1] Wanzlick,[2] and Arduengo,[3] N-heterocyclic carbenes (NHCs) have become privileged ligands in organometallic chemistry, with a wide range of applications in medicinal chemistry, materials science, and (photo)catalysis.[4, 5] Among NHCs, those developed by Arduengo, called imidazolylidenes, are the most well-known and widely used.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
